Osteopatai - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 14,815 | 20,860 | 12,851 | 13,650 | 15,650 | 18,600 | 19,200 | 21,650 |
| Profit before tax | 1,604 | 1,855 | 4,963 | 806 | 695 | 2,175 | -197 | 1,485 |
| Net profit | 1,524 | 1,855 | 4,969 | 806 | 695 | 2,065 | -197 | 1,406 |
| Equity | -12,320 | -9,160 | -4,190 | -3,385 | -2,690 | -625 | -639 | 767 |
| Liabilities | - | - | - | - | 4,361 | 4,144 | 4,996 | 6,596 |
| Non-current assets | 1,830 | 1,251 | 885 | 519 | 153 | -183 | 0 | 0 |
| Current assets | 528 | 1,797 | 2,899 | 393 | 1,518 | 3,702 | 4,357 | 7,363 |
| Total assets | 2,358 | 3,048 | 3,784 | 912 | 1,671 | 3,519 | 4,357 | 7,363 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,655 | 1,996 | 1,758 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -6.7% | +40.8% | -38.4% | +6.2% | +14.7% | +18.8% | +3.2% | +12.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 64.6% | 60.9% | 131.3% | 88.4% | 41.6% | 58.7% | -4.5% | 19.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | 183.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 10.3% | 8.9% | 38.7% | 5.9% | 4.4% | 11.1% | -1.0% | 6.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 10.8% | 8.9% | 38.6% | 5.9% | 4.4% | 11.7% | -1.0% | 6.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | 8.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 14,815 | 10,883 | 6,426 | 6,825 | 7,825 | 9,300 | 9,600 | 10,825 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Osteopatai - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-02-18 | 2026-03-05 | 0.20 |
| 2026-01-21 | 2026-02-05 | 0.20 |
| 2025-10-16 | 2025-10-19 | 289.07 |
Osteopatai - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-06-01 | 2026-06-05 | 0.65 |
| 2026-05-31 | 2026-05-31 | 0.59 |
| 2026-05-19 | 2026-05-30 | 0.81 |
| 2026-05-17 | 2026-05-18 | 79.81 |
| 2026-05-14 | 2026-05-16 | 87.16 |
| 2026-05-01 | 2026-05-11 | 5.63 |
| 2026-04-30 | 2026-04-30 | 5.42 |
| 2026-04-17 | 2026-04-29 | 4.98 |
| 2025-10-17 | 2025-10-19 | 87.55 |
| 2025-10-15 | 2025-10-16 | 86.95 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Osteopatai, MB (code 303332594) is a Lithuanian small partnership operating in medical specialists activities. In 2025, the company generated €21.6K in revenue, up 12.8% year on year and 16.4% over two years. Net profit returned to €1.4K after a small loss of €197 in 2024, following €2.1K in profit in 2023. The 2025 profit margin was 6.5%, indicating a moderate improvement in operating performance compared with the prior year. The three-year pattern shows steady revenue growth, a temporary setback in 2024, and a recovery in 2025. Balance sheet indicators also strengthened: total assets rose to €7.4K in 2025 from €4.4K in 2024, while equity moved from a negative position in 2023 and 2024 to €767 in 2025. Liabilities increased to €6.6K. Asset turnover stood at 2.94x, and revenue per employee was €10.8K. Return on equity and the debt-to-equity ratio were elevated, reflecting the company’s still limited equity base.